Sultan Al-Nozha's scientific contributions

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Baseline demographics of the study participants and unadjusted effect on QoL
Description of the unadjusted effects for depressive symptoms on QoL among diabetes patients
Full estimates for the mediation model of the PHQ score for the path between age and QoL and from DM duration and QoL score
Assessment of Quality of Life and Prevalence of Depression Among Type 1 Diabetic Patients at Prince Mansour Military Hospital, Taif, KSA
  • Article
  • Full-text available

February 2024

·

14 Reads

International Journal of Innovative Research in Medical Science

Sultan Al-Nozha

·

Khalid AlShehri

·

Manal AlJabri

·

[...]

·

Ayman Atalla

Background: Patients with diabetes were shown to report poor quality of life and significant depressive symptoms. Only a dearth of surveys was conducted to evaluate the extent of depression among Saudi patients with diabetes and how depression mediate the effect of diabetes on perceived quality of life. Method: The study is a cross sectional questionnaire-based observational investigation using a simple random sampling scheme. We utilized World Health Organization Quality of Life Brief Version (WHOQOL-BREF) and Primary Health Questionnaire PHQ-9 to evaluate depressive symptoms and quality of life. We used generalized linear regression and mediation analysis to estimate the effect of clinical and demographic variables on quality of life and the mediating effect for depressive symptoms. Results: (n = 203) agreed to be included in the study. The prevalence for severe depression was (11.3%), and for moderate depression was (18.7%) among the participating patients. Poor QoL was found in retired patients, prolonged duration of diabetes, depressive score, and experiencing DKA. Notably, we found significant interaction between duration of DM and HbA1c level in terms of their combined effect on quality of life. Among patients with prolonged diabetes duration HbA1c level was associated with poorer quality of life. However, paradoxically, among newly diagnosed diabetes patients the higher the HbA1c the better was the quality of life. Age effect was negative on the QoL, after adjusting for the HbA1c*DM duration interaction. We found that depression score significantly mediated the negative effect of age on quality of life among patients living with diabetes (Sobel test t = -2.851, p = 0.004); however, the depression-mediated effect on the path from duration of diabetes to quality-of-life score was statistically not significant (Sobel test t = -0.021, p = 0.984). Recommendations: Patients with diabetes should be screened and treated for symptoms of depression throughout the course of their illness, given their detrimental effect on their life quality. Older patients with diabetes require amelioration of depressive symptoms given their effect on life quality regardless of duration of diabetes or presence of complications.

Download
Share